Teeraya Puavilai

Learn More
Extranodal NK/T-cell lymphoma (ENKTL), nasal type, may be of NK or T-cell origin; however, the proportion of T-ENKTLs and whether they are of αβ or γδ type remains uncertain. To elucidate the cell of origin and detailed phenotype of ENKTL and assess any clinicopathologic associations, 67 cases of ENKTL from Thailand were investigated, together with 5 γδ(More)
BACKGROUND Thalidomide based regimen is an effective and well tolerated therapy in multiple myeloma (MM) patients, however, there were a small number of studies written about the results of thalidomide therapy in non-transplant MM patients. We therefore conducted a retrospective study of 42 consecutive patients with newly diagnosed and relapsed/refractory(More)
Recently, peripheral blood stem cell (PBSC) has been widely used and replaced bone marrow (BM) as the stem cell source in allogeneic hematopoietic stem cell transplantation (HSCT) because of a more rapid engraftment, easier accessibility, and lower risk of donor complications. We, therefore, report the predicting factors for the high PBSC harvest yields in(More)
Autologous hematopoietic stem cell transplantation (auto-HSCT) is the standard treatment option for multiple myeloma (MM) and relapsed non-Hodgkin's lymphoma (NHL) patients. Granulocyte colony stimulating factor (G-CSF) combined with high-dose chemotherapy is a frequently used mobilization approach. 2 Chemo-mobilization success depends on the patient's age,(More)
  • 1